Key result
Titrated VV-ECMO flow enables successful decannulation without oxygenator thrombosis in severe polycythemia.
Case Report (n=1)
No
Demonstrates that titrating VV-ECMO circuit flow to lower levels (2.8-3.0 L/min) alongside therapeutic anticoagulation can manage elevated transmembrane pressure and prevent oxygenator thrombosis in patients with marked erythrocytosis.
Answers are grounded in this paper and cite their sources.
Lower VV-ECMO flows may be feasible with anticoagulation in erythrocytosis; leaves open generalizability beyond this single case.
A 44-year-old man with obesity, hypertension, and chronic tobacco exposure developed influenza B–associated severe acute respiratory distress syndrome. Despite lung-protective ventilation and three prone-positioning attempts, refractory hypoxaemia persisted (PaO₂/FiO₂ ratio, 52; Murray score, 3). He was transferred for venovenous extracorporeal membrane oxygenation (VV-ECMO) with marked erythrocytosis (haemoglobin 17–21 g/dL); the treating team considered relative erythrocytosis consistent with Gaisböck syndrome after excluding polycythaemia vera and other secondary causes. VV-ECMO was initiated using femoral drainage and internal-jugular return cannulae. Circuit flow was initially escalated to 4 L/min but was subsequently maintained at approximately 2.8–3.0 L/min because higher flow coincided with increased transmembrane pressure. With therapeutic anticoagulation and intensive circuit surveillance, the patient was decannulated on day 8 without clinically evident oxygenator thrombosis, extubated on day 10, and discharged on day 25. This case illustrates a pragmatic, physiology-guided approach to VV-ECMO in marked erythrocytosis.
No takes yet. Share an insight, caveat, or question.
1* et al. (2026) conducted a case report in Influenza B-associated severe acute respiratory distress syndrome with marked erythrocytosis (suspected Gaisböck syndrome) (n=1). Venovenous extracorporeal membrane oxygenation (VV-ECMO) was evaluated on Successful ECMO decannulation without oxygenator thrombosis and hospital survival. Titrated VV-ECMO with therapeutic anticoagulation in a patient with haemoglobin 17-21 g/dL led to decannulation on day 8 without oxygenator thrombosis and discharge on day 25.
Synapse has enriched 10 related papers. Consider them for comparative context: